The ins and outs of molecular pathology reporting
- PMID: 28343306
- DOI: 10.1007/s00428-017-2108-0
The ins and outs of molecular pathology reporting
Abstract
The raid evolution in molecular pathology resulting in an increasing complexity requires careful reporting. The need for standardisation is clearer than ever. While synoptic reporting was first used for reporting hereditary genetic diseases, it is becoming more frequent in pathology, especially molecular pathology reports too. The narrative approach is no longer feasible with the growing amount of essential data present on the report, although narrative components are still necessary for interpretation in molecular pathology. On the way towards standardisation of reports, guidelines can be a helpful tool. There are several guidelines that focus on reporting in the field of hereditary diseases, but it is not always feasible to extrapolate these to the reporting of somatic variants in molecular pathology. The rise of multi-gene testing causes challenges for the laboratories. In order to provide a continuous optimisation of the laboratory testing process, including reporting, external quality assessment is essential and has already proven to improve the quality of reports. In general, a clear and concise report for molecular pathology can be created by including elements deemed important by different guidelines, adapting the report to the process flows of the laboratory and integrating the report with the laboratory information management system and the patient record.
Keywords: Completeness; External quality assessment; Guideline; Molecular pathology; Reporting.
Similar articles
-
Quality Assessment of Reporting Performance for EGFR Molecular Diagnosis in Non-Small Cell Lung Cancer.Oncologist. 2017 Nov;22(11):1325-1332. doi: 10.1634/theoncologist.2017-0042. Epub 2017 Jul 12. Oncologist. 2017. PMID: 28701573 Free PMC article.
-
Reporting Results of Molecular Tests: A Retrospective Examination of BRAF Mutation Reporting.Arch Pathol Lab Med. 2017 May;141(5):658-665. doi: 10.5858/arpa.2016-0280-CP. Epub 2017 Mar 13. Arch Pathol Lab Med. 2017. PMID: 28447902
-
Functional Assessment of Synoptic Pathology Reporting for Ovarian Cancer.Pathobiology. 2016;83(2-3):70-8. doi: 10.1159/000443176. Epub 2016 Apr 26. Pathobiology. 2016. PMID: 27100104
-
Guidance for laboratories performing molecular pathology for cancer patients.J Clin Pathol. 2014 Nov;67(11):923-31. doi: 10.1136/jclinpath-2014-202404. Epub 2014 Jul 10. J Clin Pathol. 2014. PMID: 25012948 Free PMC article. Review.
-
Endorsing good quality assurance practices in molecular pathology: risks and recommendations for diagnostic laboratories and external quality assessment providers.Virchows Arch. 2016 Jan;468(1):31-41. doi: 10.1007/s00428-015-1839-z. Epub 2015 Aug 26. Virchows Arch. 2016. PMID: 26306715 Review.
Cited by
-
Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer.Br J Cancer. 2024 Jul;131(2):212-219. doi: 10.1038/s41416-024-02709-4. Epub 2024 May 15. Br J Cancer. 2024. PMID: 38750115 Free PMC article. Review.
-
Co-design, implementation, and evaluation of plain language genomic test reports.NPJ Genom Med. 2022 Oct 22;7(1):61. doi: 10.1038/s41525-022-00332-x. NPJ Genom Med. 2022. PMID: 36272999 Free PMC article.
-
Reporting of somatic variants in clinical cancer care: recommendations of the Swiss Society of Molecular Pathology.Virchows Arch. 2024 Dec;485(6):1033-1039. doi: 10.1007/s00428-024-03951-0. Epub 2024 Oct 23. Virchows Arch. 2024. PMID: 39443383 Free PMC article.
-
International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA.BMC Cancer. 2018 Aug 9;18(1):804. doi: 10.1186/s12885-018-4694-x. BMC Cancer. 2018. PMID: 30092778 Free PMC article.
-
Molecular pathology testing for non-small cell lung cancer: an observational study of elements currently present in request forms and result reports and the opinion of different stakeholders.BMC Cancer. 2022 Jul 6;22(1):736. doi: 10.1186/s12885-022-09798-5. BMC Cancer. 2022. PMID: 35794532 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources